Kaia Health, a digital therapeutics company, has secured USD8 million in a funding round led by Optum Ventures.
Kaia Health has developed a smartphone-based approach for managing a number of chronic conditions, with a focus on musculoskeletal disorders (MSK) such as chronic back pain. Optum Ventures’ investment will aid Kaia Health in addressing issues their users face including the rising costs of treating MSK-related conditions and the difficulty that patients have accessing necessary treatment.
“The investment from Optum Ventures will allow us to explore integration opportunities throughout the complete patient treatment journey,” says Konstantin Mehl, Founder and CEO of Kaia Health.
Kaia Health uses 2D motion tracking technology that enables users to get real-time feedback on their exercise performance using their smartphone’s camera. The data is used in tangent with the platform’s psychological and educational support.
Optum Ventures’ investment will be used to accelerate sales growth in the US healthcare market, extend the platform into other chronic indications and expand the supporting clinical evidence base.
“Kaia Health has taken a technology-led approach to create digital therapeutics that will make treatment more accessible to patients who need it,” says Heather Roxborough, Partner at Optum Ventures. “We believe Kaia Health’s digital therapeutic solutions will benefit those suffering from MSK disorders and are excited about its application in other indications.”
